Table of Contents
1. Introduction
1.1. Introduction
1.2. Market Scope
1.2.1
Market Definition
1.2.2
Segments Covered
1.2.3
Regional
Segmentation
1.3. Research Timeframe
1.4. Currency Considered
1.5. Study Limitations
1.6. Stakeholders
1.7. List of Abbreviations
1.8. Key Conferences and Events (2025-2026)
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Market Estimation
2.3.1
Bottom-Up
Approach
2.3.2
Top-Down Approach
2.4. Market Forecasting
3. Executive Summary
3.1. Sepsis Diagnostics Market Snapshot (2025-2030)
3.2. Segment Overview
3.3. Regional Snapshot
3.4. Competitive Insights
4. Market Overview
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. High incidence of sepsis cases
globally
4.1.1.2. Increasing use of biomarker and
molecular tools
4.1.1.3. Government initiatives and growing
sepsis awareness
4.1.1.4. Rising demand for point-of-care (POC)
testing
4.1.2. Restraints
4.1.2.1. Costs & infrastructure barriers
4.1.2.2. Limited availability of diagnostics
and trained staff
4.1.2.3. Clinical complexity of sepsis
4.1.3. Opportunities
4.1.3.1. Emerging & underserved markets
4.1.3.2. Novel biomarkers & multiplex
panels
4.1.3.3. Digital biomarkers
4.2. Key Market Trends
4.2.1. Emphasis on hospital-acquired
infection (HAI) detection
4.2.2. Adoption of molecular diagnostics
4.3. Unmet Market Needs
4.4. Industry Speaks
5. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
Product, USD Million
5.1. Introduction
5.2. Instruments
5.3. Reagents & Assays
5.4. Blood Culture Media
5.5. Software & Platforms
6. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
Technology, USD Million
6.1. Introduction
6.2. Microbiology Testing
6.3. Molecular Diagnostics
6.4. Immunoassays
6.5. Flow Cytometry
6.6. Microfluidics
6.7. Others
7. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
Pathogen Type, USD Million
7.1. Introduction
7.2. Bacterial Sepsis
7.3. Fungal Sepsis
7.4. Viral Sepsis
7.5. Others
8. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
Diagnostic Method, USD Million
8.1. Introduction
8.2. Conventional Diagnostics
8.3. Automated Diagnostics
9. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
Test Type, USD Million
9.1. Introduction
9.2. Laboratory Testing
9.3. Point-of-Care Testing
10. Global Sepsis
Diagnostics Market Size & Forecast (2023-2030), By
End User, USD Million
10.1. Introduction
10.2. Hospitals & Clinics
10.3.
Diagnostic Laboratories
10.4. Others
11. Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By
Region, USD Million
11.1. Introduction
11.2. North America Sepsis Diagnostics Market
Size & Forecast (2023-2030), By Country, USD Million
11.2.1. US
11.2.1.1. Market Size
& Forecast, By Product (USD Million)
11.2.1.2. Market Size
& Forecast, By Technology (USD Million)
11.2.1.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.2.1.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.2.1.5.
Market Size
& Forecast, By Test Type (USD Million)
11.2.1.6.
Market Size
& Forecast, By End User (USD Million)
11.2.2. Canada
11.2.2.1. Market Size
& Forecast, By Product (USD Million)
11.2.2.2. Market Size
& Forecast, By Technology (USD Million)
11.2.2.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.2.2.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.2.2.5.
Market Size
& Forecast, By Test Type (USD Million)
11.2.2.6. Market Size
& Forecast, By End User (USD Million)
11.3. Europe Sepsis Diagnostics Market Size
& Forecast (2023-2030), By Country, USD Million
11.3.1. UK
11.3.1.1. Market Size
& Forecast, By Product (USD Million)
11.3.1.2. Market Size
& Forecast, By Technology (USD Million)
11.3.1.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.1.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.1.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.1.6.
Market Size
& Forecast, By End User (USD Million)
11.3.2. Germany
11.3.2.1. Market Size
& Forecast, By Product (USD Million)
11.3.2.2. Market Size
& Forecast, By Technology (USD Million)
11.3.2.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.2.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.2.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.2.6.
Market Size
& Forecast, By End User (USD Million)
11.3.3. France
11.3.3.1. Market Size
& Forecast, By Product (USD Million)
11.3.3.2. Market Size
& Forecast, By Technology (USD Million)
11.3.3.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.3.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.3.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.3.6.
Market Size
& Forecast, By End User (USD Million)
11.3.4. Italy
11.3.4.1. Market Size
& Forecast, By Product (USD Million)
11.3.4.2. Market Size
& Forecast, By Technology (USD Million)
11.3.4.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.4.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.4.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.4.6.
Market Size
& Forecast, By End User (USD Million)
11.3.5. Spain
11.3.5.1. Market Size
& Forecast, By Product (USD Million)
11.3.5.2. Market Size
& Forecast, By Technology (USD Million)
11.3.5.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.5.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.5.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.5.6.
Market Size
& Forecast, By End User (USD Million)
11.3.6. Rest of Europe
11.3.6.1. Market Size
& Forecast, By Product (USD Million)
11.3.6.2. Market Size
& Forecast, By Technology (USD Million)
11.3.6.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.3.6.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.3.6.5.
Market Size
& Forecast, By Test Type (USD Million)
11.3.6.6.
Market Size
& Forecast, By End User (USD Million)
11.4. Asia Pacific (APAC) Sepsis Diagnostics
Market Size & Forecast (2023-2030), By Country, USD Million
11.4.1. China
11.4.1.1. Market Size
& Forecast, By Product (USD Million)
11.4.1.2. Market Size
& Forecast, By Technology (USD Million)
11.4.1.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.4.1.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.4.1.5.
Market Size
& Forecast, By Test Type (USD Million)
11.4.1.6.
Market Size
& Forecast, By End User (USD Million)
11.4.2. Japan
11.4.2.1. Market Size
& Forecast, By Product (USD Million)
11.4.2.2. Market Size
& Forecast, By Technology (USD Million)
11.4.2.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.4.2.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.4.2.5.
Market Size
& Forecast, By Test Type (USD Million)
11.4.2.6.
Market Size
& Forecast, By End User (USD Million)
11.4.3. India
11.4.3.1. Market Size
& Forecast, By Product (USD Million)
11.4.3.2. Market Size
& Forecast, By Technology (USD Million)
11.4.3.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.4.3.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.4.3.5.
Market Size
& Forecast, By Test Type (USD Million)
11.4.3.6.
Market Size
& Forecast, By End User (USD Million)
11.4.4. Rest of Asia Pacific
11.4.4.1. Market Size
& Forecast, By Product (USD Million)
11.4.4.2. Market Size
& Forecast, By Technology (USD Million)
11.4.4.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.4.4.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.4.4.5.
Market Size
& Forecast, By Test Type (USD Million)
11.4.4.6.
Market Size
& Forecast, By End User (USD Million)
11.5. Latin America (LATAM) Sepsis
Diagnostics Market Size & Forecast (2023-2030), USD Million
11.5.1. Market Size
& Forecast, By Product (USD Million)
11.5.2. Market Size
& Forecast, By Technology (USD Million)
11.5.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.5.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.5.5.
Market Size
& Forecast, By Test Type (USD Million)
11.5.6.
Market Size
& Forecast, By End User (USD Million)
11.6. Middle East & Africa (MEA) Sepsis
Diagnostics Market Size & Forecast (2023-2030), USD Million
11.6.1. Market Size
& Forecast, By Product (USD Million)
11.6.2. Market Size
& Forecast, By Technology (USD Million)
11.6.3.
Market Size
& Forecast, By Pathogen Type (USD Million)
11.6.4.
Market Size
& Forecast, By Diagnostic Method (USD Million)
11.6.5.
Market Size
& Forecast, By Test Type (USD Million)
11.6.6.
Market Size
& Forecast, By End User (USD Million)
12. Competitive Landscape
12.1. Key
Players and their Competitive Positioning
12.1.1. Key
Player Comparison
12.1.2. Segment-wise
Player Mapping
12.1.3. Market
Share Analysis (2024)
12.1.4. Company
Categorization Matrix
12.1.4.1. Dominants/Leaders
12.1.4.2. New
Entrants
12.1.4.3. Emerging
Players
12.1.4.4. Innovative
Players
12.2. Key
Strategies Assessment, By Player (2022-2025)
12.2.1. New
Product Launches
12.2.2. Partnerships,
Agreements, & Collaborations
12.2.3. Mergers
& Acquisitions
12.2.4. Geographic Expansion
13. Company Profiles*
(Business
Overview, Financial Performance**, Products Offered, Recent Developments)
13.1. Biomérieux
13.2. Becton, Dickinson & Company (BD)
13.3. Danaher Corporation
13.4. F. Hoffmann-La Roche Ltd
13.5. Thermo Fisher Scientific Inc.
13.6. Bruker
13.7. Abbott Laboratories
13.8. Siemens Healthineers
13.9. Qiagen
13.10.
DiaSorin S.p.A.
13.11.
Other Prominent Players
Note: *Indicative list
**For listed companies